Cargando…

Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps—A Rapid Scoping Review

Obesity, diabetes mellitus, and cardiovascular risk are real challenges in systemic lupus erythematosus (SLE) clinical practice and research. The evidence of the burden of these health problems in SLE patients is determined by the methods used to assess them. Therefore, the aim of this scoping revie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández-Negrín, Halbert, Ricci, Michele, Mancebo-Sevilla, Juan José, Sanz-Cánovas, Jaime, López-Sampalo, Almudena, Cobos-Palacios, Lidia, Romero-Gómez, Carlos, Pérez de Pedro, Iván, Ayala-Gutiérrez, María del Mar, Gómez-Huelgas, Ricardo, Bernal-López, María Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690813/ https://www.ncbi.nlm.nih.gov/pubmed/36429489 http://dx.doi.org/10.3390/ijerph192214768

Ejemplares similares

COVID-19 in Older Patients: Assessment of Post-COVID-19 Sarcopenia
por: López-Sampalo, Almudena, et al.
Publicado: (2023)

Remission of type 2 diabetes: A critical appraisal
por: Ricci, Michele, et al.
Publicado: (2023)

Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia
por: Sanz-Cánovas, Jaime, et al.
Publicado: (2022)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2022)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Jansen-Chaparro, Sergio, et al.
Publicado: (2021)

Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2020)

Síndrome de COVID-19 persistente. Una revisión narrativa
por: López-Sampalo, A., et al.
Publicado: (2022)

Persistent COVID-19 syndrome. A narrative review()
por: López-Sampalo, A., et al.
Publicado: (2022)

De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population
por: Cobos-Palacios, Lidia, et al.
Publicado: (2022)

Lifestyle Modification Program on a Metabolically Healthy Elderly Population with Overweight/Obesity, Young-Old vs. Old-Old. CONSEQUENCES of COVID-19 Lockdown in This Program
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Blood Composite Scores in Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Júlia, et al.
Publicado: (2023)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
por: García-González, María, et al.
Publicado: (2023)

Classifying discoid lupus erythematosus: background, gaps, and difficulties()()()
por: Haber, Jessica S., et al.
Publicado: (2017)

Classifying discoid lupus erythematosus: background, gaps, and difficulties()()
por: Haber, Jessica S., et al.
Publicado: (2016)

Adipokines Profile and Inflammation Biomarkers in Prepubertal Population with Obesity and Healthy Metabolic State
por: Cobos-Palacios, Lidia, et al.
Publicado: (2022)

Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Bilateral striopallidal calcinosis secondary to systemic lupus erythematosus
por: Betancur, Juan Felipe, et al.
Publicado: (2022)

Epigenetic Mechanisms and Posttranslational Modifications in Systemic Lupus Erythematosus
por: Navarro Quiroz, Elkin, et al.
Publicado: (2019)

Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
por: García-González, María, et al.
Publicado: (2023)

Direct healthcare cost of pediatric systemic lupus erythematosus in the Philippines
por: Yee, Maria Kathryn Ramirez, et al.
Publicado: (2023)

Latent orbital pseudotumor secondary to systemic lupus erythematosus
por: Rico, María, et al.
Publicado: (2016)

Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
por: Fernández-Cladera, Yolanda, et al.
Publicado: (2023)

Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Julia, et al.
Publicado: (2023)

Remdesivir in Very Old Patients (≥80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry
por: Ramos-Rincon, Jose-Manuel, et al.
Publicado: (2022)

Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network
por: Fernández-Garcés, Mar, et al.
Publicado: (2019)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain()
por: Salinas-Botrán, A., et al.
Publicado: (2022)

Características clínicas y factores de riesgo de mortalidad al ingreso en pacientes con insuficiencia cardíaca hospitalizados por COVID-19 en España
por: Salinas-Botrán, A., et al.
Publicado: (2022)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Measurement properties of the brief resilient coping scale in patients with systemic lupus erythematosus using rasch analysis
por: López-Pina, José-Antonio, et al.
Publicado: (2016)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
por: Monzón Manzano, Elena, et al.
Publicado: (2020)

Biomarkers and the quadriceps femoris muscle architecture assessed by ultrasound in older adults with heart failure with preserved ejection fraction: a cross-sectional study
por: Fuentes-Abolafio, Iván José, et al.
Publicado: (2022)

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches
por: López-Pedrera, Chary, et al.
Publicado: (2010)

Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
por: Merino de Paz, Nayra, et al.
Publicado: (2023)

C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19
por: Giner-Galvañ, Vicente, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ee0kf2e11jfohk5iueu2bken36